Cell-free DNA Levels in Herpes Zoster: A Cross-sectional Longitudi­nal Study

Authors

  • Chaya Bracha Gordon Ben Gurion University of the Negev, Faculty of Health Sciences, Beer-Sheva, Israel
  • Yaron Zenaty Ben Gurion University of the Negev, Faculty of Health Sciences, Beer-Sheva, Israel
  • Ayelet Ollech Pediatric Dermatology Service, Shaare Zedek Medical Center, Jerusalem, Israel; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
  • Gidon Test 4Pediatric Emergency Department, Soroka University Medical Center, Beer-Sheva, Israel
  • Amos Douvdevani Ben Gurion University of the Negev, Faculty of Health Sciences, Beer-Sheva, Israel; Department of Clinical Biochemistry, Soroka Medical Center, Beer-Sheva, Israel
  • Amir Horev Ben Gurion University of the Negev, Faculty of Health Sciences, Beer-Sheva, Israel; Pediatric Dermatology Service, Soroka University Medical Center, Beer-Sheva, Israel

DOI:

https://doi.org/10.2340/actadv.v105.42137

Keywords:

herpes zoster, post-herpetic neuralgia, human herpes virus, cell-free DNA, inflammation marker.

Abstract

This study investigates serum cell-free DNA fluctuations in patients with herpes zoster or post-herpetic neuralgia, offering insight into the tissue damage and inflammatory dynamics associated with these conditions. A single-centre combined cross-sectional and longitudinal study was conducted with 59 patients to assess cell-free DNA levels in herpes zoster and post-herpetic neuralgia. Cell-free DNA was extracted from blood samples of patients with herpes zoster or post-herpetic neuralgia and compared with healthy controls. The findings demonstrated elevated cell-free DNA levels in patients with herpes zoster, which remained elevated for 3 months or longer following treat-ment. These results suggest the presence of a subacute inflammatory state after herpes zoster infection. Furthermore, patients who developed post-herpetic neuralgia did not show elevated cell-free DNA levels, while those who did not develop post-herpetic neuralgia exhibited increased levels. This indicates that post-herpetic neuralgia is likely a localized response to prior nerve damage rather than a systemic inflammatory process with acute tissue damage.

Downloads

Download data is not yet available.

References

Apr2014_session6_herpes_zoster.pdf [Internet]. [cited 2024 Sep 16]. Available from: https://terrance.who.int/mediacentre/data/sage/SAGE_Docs_Ppt_Apr2014/6_session_varicella_herpes_zoster/Apr2014_session6_herpes_zoster.pdf

Giannelos N, Curran D, Nguyen C, Kagia C, Vroom N, Vroling H. The incidence of herpes zoster complications: a systematic literature review. Infect Dis Ther 2024 Jul 1;13:1461-1486.

https://doi.org/10.1007/s40121-024-01002-4 DOI: https://doi.org/10.1007/s40121-024-01002-4

Zhang Q, Huang ZS, Hu QQ, Qin W, Liang LL, Cui F, et al. [Quality of life and risk factors in patients with herpes zoster]. Zhonghua Yi Xue Za Zhi. 2022; 102: 3395-3400.

Díez-Domingo J, Curran D, Cambronero MDR, Garcia-Martinez JA, Matthews S. Economic burden and impact on quality of life of herpes zoster in Spanish adults aged 50 years or older: a prospective cohort study. Adv Ther 2021; 38: 3325-3341.

https://doi.org/10.1007/s12325-021-01717-7 DOI: https://doi.org/10.1007/s12325-021-01717-7

Du J, Sun G, Ma H, Xiang P, Guo Y, Deng Y, et al. Prevalence and risk factors of anxiety and depression in patients with postherpetic neuralgia: a retrospective study. Dermatology 2020; 237: 891-895.

https://doi.org/10.1159/000512190 DOI: https://doi.org/10.1159/000512190

Li Y, Jin J, Kang X, Feng Z. Identifying and evaluating biological markers of postherpetic neuralgia: a comprehensive review. Pain Ther 2024; 13: 1095-1117.

https://doi.org/10.1007/s40122-024-00640-3 DOI: https://doi.org/10.1007/s40122-024-00640-3

González-Jiménez P, Méndez R, Latorre A, Piqueras M, Balaguer-Cartagena MN, Moscardó A, et al. Neutrophil extracellular traps and platelet activation for identifying severe episodes and clinical trajectories in COVID-19. Int J Mol Sci 2023; 24: 6690.

https://doi.org/10.3390/ijms24076690 DOI: https://doi.org/10.3390/ijms24076690

Sandquist M, Wong HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol 2014; 10: 1349-1356.

https://doi.org/10.1586/1744666X.2014.949675 DOI: https://doi.org/10.1586/1744666X.2014.949675

Yi J, Zhang Y, Zhang Y, Ma Y, Zhang C, Li Q, et al. Increased plasma cell-free DNA level during HTNV infection: correlation with disease severity and virus load. Viruses 2014; 6: 2723-2734.

https://doi.org/10.3390/v6072723 DOI: https://doi.org/10.3390/v6072723

Bazemore K, Permpalung N, Mathew J, Lemma M, Haile B, Avery R, et al. Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction. Am J Transplant 2022; 22: 2560-2570.

https://doi.org/10.1111/ajt.17125 DOI: https://doi.org/10.1111/ajt.17125

Lu Y, Zhang Y, Lou Z, He X, Zhang Q, Zhang Q, et al. Metagenomic next-generation sequencing of cell-free DNA for the identification of viruses causing central nervous system infections. Microbiol Spectr 2023; 12: e02264-23.

https://doi.org/10.1128/spectrum.02264-23 DOI: https://doi.org/10.1128/spectrum.02264-23

Guiraud V, Thévenet H, Boutolleau D. Detection of varicella zoster virus DNA in blood from immunocompromised patients during the week preceding the onset of herpes zoster rash. J Clin Virol 2023; 169: 105609.

https://doi.org/10.1016/j.jcv.2023.105609 DOI: https://doi.org/10.1016/j.jcv.2023.105609

Beebe A, McCaffery M. Pain: Clinical manual for nursing practice. St. Louis: Mosby.

Goldshtein H, Hausmann MJ, Douvdevani A. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem 2009; 46: 488-494.

https://doi.org/10.1258/acb.2009.009002 DOI: https://doi.org/10.1258/acb.2009.009002

van der Meer AJ, Kroeze A, Hoogendijk AJ, Soussan AA, Ellen van der Schoot C, Wuillemin WA, et al. Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans. Blood Adv 2019; 3: 724-728.

https://doi.org/10.1182/bloodadvances.2018018895 DOI: https://doi.org/10.1182/bloodadvances.2018018895

De Luca G, Lev PR, Camacho MF, Goette NP, Sackmann F, Castro Ríos MA, et al. High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis. Front Immunol 2023; 14: 1161832.

https://doi.org/10.3389/fimmu.2023.1161832 DOI: https://doi.org/10.3389/fimmu.2023.1161832

Urosevic N, Merritt AJ, Inglis TJJ. Plasma cfDNA predictors of established bacteraemic infection. Access Microbiol 2022; 4: 000373.

https://doi.org/10.1099/acmi.0.000373 DOI: https://doi.org/10.1099/acmi.0.000373

Jing Q, Leung CHC, Wu AR. Cell-free DNA as biomarker for sepsis by integration of microbial and host information. Clin Chem 2022; 68: 1184-1195.

https://doi.org/10.1093/clinchem/hvac097 DOI: https://doi.org/10.1093/clinchem/hvac097

Hovhannisyan G, Harutyunyan T, Aroutiounian R, Liehr T. The diagnostic, prognostic, and therapeutic potential of cell-free DNA with a special focus on COVID-19 and other viral infections. Int J Mol Sci 2023; 24: 14163.

https://doi.org/10.3390/ijms241814163 DOI: https://doi.org/10.3390/ijms241814163

Hammad R, Eldosoky MAER, Fouad SH, Elgendy A, Tawfeik AM, Alboraie M, et al. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity. Innate Immun 2021; 27: 240-250.

https://doi.org/10.1177/1753425921995577 DOI: https://doi.org/10.1177/1753425921995577

Johnston DGW, Hambly R, Kearney N, Tobin DJ, Kirby B. Cell‐free DNA is elevated in the serum of patients with hidradenitis suppurativa. J Dermatol 2023; 50: 271-273.

https://doi.org/10.1111/1346-8138.16676 DOI: https://doi.org/10.1111/1346-8138.16676

Elevation of cell‐free DNA in patients with clinically amyopathic dermatomyositis. [cited 2024 Sep 23]. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.16714

Devor M. Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: the ectopic pacemaker hypothesis. Pain Rep 2018; 3: e702.

https://doi.org/10.1097/PR9.0000000000000702 DOI: https://doi.org/10.1097/PR9.0000000000000702

Ng H, Havervall S, Rosell A, Aguilera K, Parv K, Meijenfeldt FA von, et al. Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19. Arterioscler Thromb Vasc Biol 2021; 41: 988.

https://doi.org/10.1161/ATVBAHA.120.315267 DOI: https://doi.org/10.1161/ATVBAHA.120.315267

Eichenberger EM, Degner N, Scott ER, Ruffin F, Franzone J, Sharma-Kuinkel B, et al. Microbial cell-free dna identifies the causative pathogen in infective endocarditis and remains detectable longer than conventional blood culture in patients with prior antibiotic therapy. Clin Infect Dis 2022; 76: e1492-1500.

https://doi.org/10.1093/cid/ciac426 DOI: https://doi.org/10.1093/cid/ciac426

Heldman MR, Ahmed AA, Liu W, Vo A, Keane-Candib J, Stevens-Ayers T, et al. Serial quantitation of plasma microbial cell-free DNA before and after diagnosis of pulmonary invasive mold infections after hematopoietic cell transplant. J Infect Dis. 2024; 229: 576-587.

https://doi.org/10.1093/infdis/jiad255 DOI: https://doi.org/10.1093/infdis/jiad255

Mijiddorj T, Kajihara I, Tasaki Y, Otsuka-Maeda S, Sakamoto R, Sawamura S, et al. Serum cell-free DNA levels are a useful marker for extramammary Paget disease. Br J Dermatol 2019; 181: 505-511.

https://doi.org/10.1111/bjd.17709 DOI: https://doi.org/10.1111/bjd.17709

Horev A, Horev A, Gordon-Irshai A, Gordon M, Andre N, Ifergane G. Herpes zoster and long-term vascular risk: a retrospective cohort study. Sci Rep 2023; 13: 2364.

https://doi.org/10.1038/s41598-023-29667-w DOI: https://doi.org/10.1038/s41598-023-29667-w

Parameswaran GI, Wattengel BA, Chua HC, Swiderek J, Fuchs T, Carter MT, et al. Increased stroke risk following herpes zoster infection and protection with zoster vaccine. Clin Infect Dis. 2023; 76: e1335-1340.

https://doi.org/10.1093/cid/ciac549 DOI: https://doi.org/10.1093/cid/ciac549

Theron A, Dautremay O, Boissier E, Zerroukhi A, Baleine J, Moulis L, et al. Idiopathic purpura fulminans associated with anti-protein S antibodies in children: a multicenter case series and systematic review. Blood Adv 2022; 6: 495-502.

https://doi.org/10.1182/bloodadvances.2021005126 DOI: https://doi.org/10.1182/bloodadvances.2021005126

Published

2025-01-03

How to Cite

Gordon, C. B., Zenaty, Y., Ollech, A., Test, G., Douvdevani, A., & Horev, A. (2025). Cell-free DNA Levels in Herpes Zoster: A Cross-sectional Longitudi­nal Study. Acta Dermato-Venereologica, 105, adv42137. https://doi.org/10.2340/actadv.v105.42137